Funding tracker
Precision Neuroscience raised $250M
$250MRaised
Series DStage
25 Sept 2026Date
68.5KViews on the announcement
The round
| Amount | $250M |
|---|---|
| Stage | Series D |
| Investors | not stated |
| What they do | Brain-computer interface |
| Vertical | Health and bio |
| First reported | Friday, 25 September 2026 |
The announcement on X
The median tracked announcement from accounts with under 10K followers reached 13.4K views (201 posts). This one did 5.1x that.
Precision Neuroscience has closed an oversubscribed $250M Series D, co-led by @PershingSquare Capital Management, The Ackman Oxman Institute, and a leading life sciences investment fund. Total raised: ~$430M. But the financing is only part of the story. Precision now has completed 100+ procedures across 18 major medical institutions. Building BCI requires more than an interface. It requires clinical infrastructure. Since our last financing @PrecisionNeuro_ has also: - Received @FDA clearance for Layer 7™ - Expanded peer-review clinical research - Partnered with @Medtronic - Expanded U.S. MEMS manufacturing The next phase of BCI will be defined not only by what the technology can do in a laboratory. It will be defined by whether companies can build the clinical, regulatory, and manufacturing infrastructure required to bring it to patients. This funding will support: - Expanded clinical work - Additional FDA review - Commercialization infrastructure Read the full news release here: https://t.co/xWitHdEY6n @BillAckman @PershingSquare @BCapitalGroup, @ARKInvest, @MubadalaCapital, @MiraeAsset, @Hitachi Ventures. Precision’s brain-computer interface is an investigational device and is not available for sale in the United States.
| Posted by | @PrecisionNeuro_ (Precision Neuroscience) |
|---|---|
| Followers | 1,328 |
| Views | 68,538 |
| Views per follower | 52x |
| Likes | 63 |
| Reposts | 6 |
| Bookmarks | 20 |
Similar rounds
| Company | Stage | Amount | Lead | On X | Date |
|---|---|---|---|---|---|
| DailyPay | Series D | $175M | Carrick Capital Partners | - | 26 Sept 2026 |
| RightwayNext-generation pharmacy benefits | Series E+ | $155M | - | - | 24 Sept 2026 |
| Luma Health | Series C | $130M | FTV Capital | - | 26 Sept 2026 |
| Canary Technologies | Series D | $80M | Brighton Park Capital | - | 26 Sept 2026 |
| Basalt HealthAI referral platform | Series A | $20M | NEA | - | 24 Sept 2026 |
| TEKEVERAI drone maker | Series D | $580M | - | - | 23 Sept 2026 |
Next launch
Planning a launch?
Tell us what is launching and when. Thirty minutes is usually enough to know whether we are the right team for it.